2021
DOI: 10.1136/annrheumdis-2021-eular.3297
|View full text |Cite
|
Sign up to set email alerts
|

Ab0776 multiple Autoimmune Syndrome

Abstract: Background:Multiple autoimmune syndrome (MAS) is a rare entity, defined by the association of three autoimmune diseases in the same patient. MAS can be classified into three groups.Objectives:The objective of this work was to describe the autoimmune diseases profile in MAS in An Internal Medicine Department.Methods:We report a retrospective analysis including 14 cases of MAS seen in The Internal Medicine Department at Taher Sfar Hospital, Mahdia, TUNISIA over a period of 10 years.Results:We followed 14 patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The prevalence and incidence of SS in patients of both sexes with inflammatory bowel disease are the same compared to control groups [18,19] . Many studies revealed that a large number of patients with UC developed RA within a few years, but very rare cases have been published of ulcerative colitis developing in rheumatoid arthritis [20][21][22] . About 25 percent of patients with autoimmune diseases tend to develop additional autoimmune diseases [17] .…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence and incidence of SS in patients of both sexes with inflammatory bowel disease are the same compared to control groups [18,19] . Many studies revealed that a large number of patients with UC developed RA within a few years, but very rare cases have been published of ulcerative colitis developing in rheumatoid arthritis [20][21][22] . About 25 percent of patients with autoimmune diseases tend to develop additional autoimmune diseases [17] .…”
Section: Discussionmentioning
confidence: 99%